caa a22 4500 606203664 CHVBK 20210128100958.0 cr unu---uuuuu 210128e20150301xx s 000 0 eng 10.1007/s10484-015-9273-1 doi (NATIONALLICENCE)springer-10.1007/s10484-015-9273-1 Chronic Pelvic Pain Syndrome: Reduction of Medication Use After Pelvic Floor Physical Therapy with an Internal Myofascial Trigger Point Wand [Elektronische Daten] [Rodney Anderson, Richard Harvey, David Wise, J. Nevin Smith, Brian Nathanson, Tim Sawyer] This study documents the voluntary reduction in medication use in patients with refractory chronic pelvic pain syndrome utilizing a protocol of pelvic floor myofascial trigger point release with an FDA approved internal trigger point wand and paradoxical relaxation therapy. Self-referred patients were enrolled in a 6-day training clinic from October, 2008 to May, 2011 and followed the protocol for 6months. Medication usage and symptom scores on a 1-10 scale (10=most severe) were collected at baseline, and 1 and 6months. All changes in medication use were at the patient's discretion. Changes in medication use were assessed by McNemar's test in both complete case and modified intention to treat (mITT) analyses. 374 out of 396 patients met inclusion criteria; 79.7% were male, median age of 43years and median symptom duration of 5years. In the complete case analysis, the percent of patients using medications at baseline was 63.6%. After 6months of treatment the percentage was 40.1%, a 36.9% reduction (p<0.001). In the mITT analysis, there was a 22.7% overall reduction from baseline (p<0.001). Medication cessation at 6months was significantly associated with a reduction in total symptoms (p=0.03). Springer Science+Business Media New York, 2015 Myofascial trigger point release nationallicence Chronic pelvic pain syndrome nationallicence Paradoxical relaxation nationallicence Physical therapy nationallicence CP/CPPS : Chronic prostatitis/chronic pelvic pain syndrome nationallicence CPPS : Urologic chronic pelvic pain syndrome nationallicence NIH-CPSI : National Institutes of Health Chronic Prostatitis Symptoms nationallicence TrP : Trigger point nationallicence Anderson Rodney Stanford University School of Medicine, 574 Junipero Serra Blvd, 94305, Stanford, CA, USA aut Harvey Richard Department of Health Education, San Francisco State University, San Francisco, CA, USA aut Wise David National Center for Pelvic Pain Research, Sebastopol, CA, USA aut Nevin Smith J. Sonoma, CA, USA aut Nathanson Brian OptiStatim, LLC, Longmeadow, MA, USA aut Sawyer Tim National Center for Pelvic Pain Research, Sebastopol, CA, USA aut Applied Psychophysiology and Biofeedback Springer US; http://www.springer-ny.com 40/1(2015-03-01), 45-52 1090-0586 40:1<45 2015 40 10484 https://doi.org/10.1007/s10484-015-9273-1 text/html Onlinezugriff via DOI BK010053 XK010053 XK010000 Metadata rights reserved Springer special CC-BY-NC licence nationallicence 1 research-article jats NATIONALLICENCE NATIONALLICENCE NL-springer NATIONALLICENCE 856 40 https://doi.org/10.1007/s10484-015-9273-1 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Anderson Rodney Stanford University School of Medicine, 574 Junipero Serra Blvd, 94305, Stanford, CA, USA aut NATIONALLICENCE 700 1- Harvey Richard Department of Health Education, San Francisco State University, San Francisco, CA, USA aut NATIONALLICENCE 700 1- Wise David National Center for Pelvic Pain Research, Sebastopol, CA, USA aut NATIONALLICENCE 700 1- Nevin Smith J. Sonoma, CA, USA aut NATIONALLICENCE 700 1- Nathanson Brian OptiStatim, LLC, Longmeadow, MA, USA aut NATIONALLICENCE 700 1- Sawyer Tim National Center for Pelvic Pain Research, Sebastopol, CA, USA aut NATIONALLICENCE 773 0- Applied Psychophysiology and Biofeedback Springer US; http://www.springer-ny.com 40/1(2015-03-01), 45-52 1090-0586 40:1<45 2015 40 10484